Skip to main content
logo
Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
1.340
-0.050 (-3.60%)
Apr 16, 2026, 4:00 PM EDT - Market closed

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3384723
Market Cap Growth
-32.77%-66.35%100.85%-39.76%-71.05%-32.20%
Enterprise Value
-1.81-1.843.84-7.6-13.09-3.29
Last Close Price
1.341.985.923.1310.8441.60
PE Ratio
--1.16-1.15-0.73-0.61-1.51
PS Ratio
0.570.561.600.900.903.40
PB Ratio
0.440.661.300.310.320.74
P/TBV Ratio
0.440.651.300.300.310.71
P/FCF Ratio
--0.57-0.84-0.26-0.48-0.86
P/OCF Ratio
--0.57-0.84-0.26-0.48-0.89
EV/Sales Ratio
--0.380.76-1.71-1.76-0.49
EV/EBITDA Ratio
-0.79-1.331.491.040.10
EV/EBIT Ratio
-0.74-1.051.250.930.09
EV/FCF Ratio
-0.39-0.400.500.930.12
Debt / Equity Ratio
-000.010.050.07
Debt / EBITDA Ratio
---0.05-0.20-0.16-0.10
Debt / FCF Ratio
---0.02-0.07-0.14-0.12
Net Debt / Equity Ratio
-1.10-1.10-0.66-0.83-0.89-0.82
Net Debt / EBITDA Ratio
1.951.951.422.081.470.77
Net Debt / FCF Ratio
0.960.960.420.701.330.95
Asset Turnover
0.480.480.300.180.200.15
Inventory Turnover
2.932.933.401.381.812.11
Quick Ratio
2.422.422.113.385.195.96
Current Ratio
3.093.093.614.176.037.02
Return on Equity (ROE)
-44.99%-45.14%-45.62%-83.24%-59.94%-54.01%
Return on Assets (ROA)
-24.99%-25.01%-22.00%-25.13%-38.51%-77.86%
Return on Invested Capital (ROIC)
-68.10%-68.16%-54.88%-105.58%-164.83%-243.60%
Return on Capital Employed (ROCE)
-32.36%-32.38%-26.95%-29.89%-44.05%-88.91%
Earnings Yield
-84.86%-86.36%-87.33%-137.38%-163.01%-66.25%
FCF Yield
-171.94%-174.31%-119.34%-380.28%-210.37%-116.48%
Buyback Yield / Dilution
-0.35%-0.35%-10.22%-106.37%-12.66%-113.68%
Total Shareholder Return
-0.35%-0.35%-10.22%-106.37%-12.66%-113.68%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q